Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence

被引：23

作者：

Bellmann, R

Egger, P

Wiedermann, CJ

机构：

[1] Univ Innsbruck, Dept Internal Med, Intens Care Unit, A-6020 Innsbruck, Austria

[2] Univ Innsbruck, Clin Pharmacokinet Unit, Med Intens Care Res Lab, A-6020 Innsbruck, Austria

来源：

CLINICAL INFECTIOUS DISEASES | 2003年 / 36卷 / 11期

关键词：

D O I：

10.1086/374876

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1500 / 1501

页数：2

共 24 条

[11] Lipid formulations of amphotericin B: Recent progress and future directions
Hiemenz, JW
Walsh, TJ
[J]. CLINICAL INFECTIOUS DISEASES, 1996, 22 : S133 - S144
[12] Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia - Reply
Hughes, W
Armstrong, D
Bodey, G
Bow, E
Brown, A
Calandra, T
Feld, R
Pizzo, P
Rolston, K
Shenep, J
Young, L
[J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (07) : 897 - 898
[13] 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, WT
Armstrong, D
Bodey, GP
Bow, EJ
Brown, AE
Calandra, T
Feld, R
Pizzo, PA
Rolston, KVI
Shenep, JL
Young, LS
[J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) : 730 - 751
[14] LIPOSOMAL AND LIPID FORMULATIONS OF AMPHOTERICIN-B - CLINICAL PHARMACOKINETICS
JANKNEGT, R
DEMARIE, S
BAKKERWOUDENBERG, IAJM
CROMMELIN, DJA
[J]. CLINICAL PHARMACOKINETICS, 1992, 23 (04) : 279 - 291
[15] Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections
Leenders, ACAP
Daenen, S
Jansen, RLH
Hop, WCJ
Lowenberg, B
Wijermans, PW
Cornelissen, J
Herbrecht, R
Van der Lelie, H
Hoogsteden, HC
Verbrugh, HA
de Marie, S
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (01) : 205 - 212
[16] LIPOSOMAL AMPHOTERICIN-B IN THE TREATMENT OF FUNGAL-INFECTIONS IN NEUTROPENIC PATIENTS - A SINGLE-CENTER EXPERIENCE OF 133 EPISODES IN 116 PATIENTS
MILLS, W
CHOPRA, R
LINCH, DC
GOLDSTONE, AH
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (04) : 754 - 760
[17] LIPOSOMAL AMPHOTERICIN-B (AMBISOME) THERAPY IN INVASIVE FUNGAL-INFECTIONS - EVALUATION OF UNITED-KINGDOM COMPASSIONATE USE DATA
NG, TTC
DENNING, DW
[J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (10) : 1093 - 1098
[18] RINGDEN O, 1992, LANCET, V339, P374, DOI 10.1016/0140-6736(92)91698-8
[19] RINGDEN O, 1994, TRANSPL P, V26, P187
[20] SINGLE-DOSE PHARMACOKINETICS AND TOLERANCE OF A CHOLESTERYL SULFATE COMPLEX OF AMPHOTERICIN-B ADMINISTERED TO HEALTHY-VOLUNTEERS
SANDERS, SW
BUCHI, KN
GODDARD, MS
LANG, JK
TOLMAN, KG
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (06) : 1029 - 1034

← 1 2 3 →